trimethoprim has been researched along with Thrombocytopathy in 2 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Claas, FH | 1 |
| van der Meer, JW | 1 |
| Langerak, J | 1 |
| Dry, J | 1 |
| Leynadier, F | 1 |
| Herman, D | 1 |
| Pradalier, A | 1 |
2 other studies available for trimethoprim and Thrombocytopathy
| Article | Year |
|---|---|
Immunological effect of co-trimoxazole on platelets.
Topics: Adult; Antibodies; Blood Platelet Disorders; Blood Platelets; Cell Survival; Drug Combinations; Fema | 1979 |
[Letter: Sulfamethoxazole-trimethoprim combination (cotrimoxazole). Unusual immuno-allergic reaction].
Topics: Blood Platelet Disorders; Drug Combinations; Drug Hypersensitivity; Drug Tolerance; Female; Humans; | 1975 |